Cargando…
Therapeutic Use and Molecular Aspects of Ivabradine in Cardiac Remodeling: A Review
Cardiac remodeling can cause ventricular dysfunction and progress to heart failure, a cardiovascular disease that claims many lives globally. Ivabradine, a funny channel (I(f)) inhibitor, is used in patients with chronic heart failure as an adjunct to other heart failure medications. This review aim...
Autores principales: | Kamisah, Yusof, Che Hassan, Hamat H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917668/ https://www.ncbi.nlm.nih.gov/pubmed/36769115 http://dx.doi.org/10.3390/ijms24032801 |
Ejemplares similares
-
Molecular mechanisms of sacubitril/valsartan in cardiac remodeling
por: Mustafa, Nor Hidayah, et al.
Publicado: (2022) -
Role of Trientine in Hypertrophic Cardiomyopathy: A Review of Mechanistic Aspects
por: Ramli, Fitri Fareez, et al.
Publicado: (2022) -
Ivabradine improves survival and attenuates cardiac remodeling in isoproterenol‐induced myocardial injury
por: Simko, Fedor, et al.
Publicado: (2020) -
Effect of Ivabradine on Cardiac Ventricular Arrhythmias: Friend or Foe?
por: Oknińska, Marta, et al.
Publicado: (2021) -
Ivabradine: the evidence of its therapeutic impact in angina
por: Marquis-Gravel, Guillaume, et al.
Publicado: (2008)